Log in to save to my catalogue

Toxicity of kava pyrones, drug safety and precautions – a case study

Toxicity of kava pyrones, drug safety and precautions – a case study

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_205534235

Toxicity of kava pyrones, drug safety and precautions – a case study

About this item

Full title

Toxicity of kava pyrones, drug safety and precautions – a case study

Publisher

Germany: Elsevier GmbH

Journal title

Phytomedicine (Stuttgart), 2003-01, Vol.10 (4), p.68-73

Language

English

Formats

Publication information

Publisher

Germany: Elsevier GmbH

More information

Scope and Contents

Contents

Kava pyrones have been sold in Germany as OTC anxiolytics until June 2002, when all preparations with a kava pyrone content of more than 10
–4 of a homeopathic stock solution were withdrawn. Other countries in which kava pyrones have been used as anxiolytics, namely GB and the USA, have not followed suit. Kava pyrone anxiolytics have been positi...

Alternative Titles

Full title

Toxicity of kava pyrones, drug safety and precautions – a case study

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_205534235

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_205534235

Other Identifiers

ISSN

0944-7113

E-ISSN

1618-095X

DOI

10.1078/1433-187X-00300

How to access this item